Vascular Inflammation Stratified by Body Size Phenotype
- Conditions
- ObesityMetabolic SyndromeAtherosclerosis
- Registration Number
- NCT01979068
- Lead Sponsor
- Korea University
- Brief Summary
* Vascular Inflammation is a key factor in both the pathogenesis and outcome of atherosclerosis. 18FDG-PET is a promising novel tool for identifying and quantifying vascular inflammation within atherosclerotic plaque
* Recently, unique subsets of obese individuals, such as metabolically obese but normal weight (MONW) and metabolically healthy obese (MHO), have been getting an attention
* Therefore, the purpose of this study is to examine the relationship of vascular inflammation,measured by FDG-PET, with various body sized phenotypes
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 250
- Healthy patients for visiting routine medical check in our clinic
- history of CVD (myocardial infarction, unstable angina, stroke, or cardiovascular revascularization)
- stage 2 hypertension (resting blood pressure, ≥160/100 mmHg)
- history of inflammatory conditions that affect the study results
- taking medications that might affect inflammatory status, including steroid and non-steroidal anti-inflammatory drug within 6 months
- or malignancy or severe renal or hepatic disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method max TBR values stratified by the four body size phenotypes 12 weeks
- Secondary Outcome Measures
Name Time Method Framingham risk scores according to the four body size phenotypes 12 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Korea University Guro Hospital
🇰🇷Seoul, Korea, Republic of
Korea University Guro Hospital🇰🇷Seoul, Korea, Republic of